Finance
Fresenius Medical Care's stock falls on Fresenius' stake sale
Published by Global Banking & Finance Review®
Posted on March 4, 2025
1 min readLast updated: January 25, 2026
Global Banking & Finance Review®
Company
Published by Global Banking & Finance Review®
Posted on March 4, 2025
1 min readLast updated: January 25, 2026
Fresenius SE reduced its stake in Fresenius Medical Care, causing a 7.8% drop in FMC shares. The sale raised 1.1 billion euros.
(Reuters) -Dialysis firm Fresenius Medical Care shares fell 7.8% after German healthcare group Fresenius SE sold part of its stake in the company.
Fresenius SE, which previously owned 32.2% of FMC, cut its stake to 25% plus one share via an accelerated bookbuilding procedure as well as through the placement of bonds exchangeable into FMC shares, it said in a statement.
Gross proceeds from the transactions amounted to around 1.1 billion euros ($1.2 billion), Fresenius said, adding that these will be used in line with stated capital allocation priorities.
Fresenius SE's stock declined 0.41%.
($1 = 0.9511 euros)
(Reporting by Tristan Veyet in GdanskEditing by Ludwig Burger)
The main topic is Fresenius SE's reduction of its stake in Fresenius Medical Care and the resulting impact on share prices.
Fresenius SE raised approximately 1.1 billion euros from the stake sale.
Fresenius Medical Care's shares fell by 7.8% following the stake sale.
Explore more articles in the Finance category
